Profil
Nick la Thangue is the founder of Oxford Cancer Biomarkers Ltd., founded in 2012, holding the title of Chief Operating Officer & Director.
Dr. la Thangue is also the founder of Celleron Therapeutics Ltd...
Dr. la Thangue currently holds the positions of Chief Executive Officer & Director at Ingenox Therapeutics Ltd. and Director at Synox Therapeutics Ltd.
Postes actifs de Nick la Thangue
| Sociétés | Poste | Début |
|---|---|---|
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Fondateur | 01/01/2012 |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Directeur Général | - |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Directeur/Membre du Conseil | - |
Ingenox Therapeutics Ltd.
Ingenox Therapeutics Ltd. BiotechnologyHealth Technology Develops drugs and precision cancer vaccines for advanced & treatment-resistant cancers | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Health Technology |
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Health Technology |
Ingenox Therapeutics Ltd.
Ingenox Therapeutics Ltd. BiotechnologyHealth Technology Develops drugs and precision cancer vaccines for advanced & treatment-resistant cancers | Health Technology |
















